Anja Mehnert1, Uwe Koch. 1. Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. mehnert@uke.uni-hamburg.de
Abstract
OBJECTIVE: Psychosocial comorbidity and quality of life (QOL) and its association with knowledge, utilization, and need for psychosocial support have been studied in long-term breast cancer survivors. METHODS: One thousand eighty-three patients were recruited through a population-based cancer registry an average of 47 months following diagnosis (66% response rate). Self-report measures (e.g., Hospital Anxiety and Depression Scale, Posttraumatic Stress Disorder Checklist--Civilian Version, and Short-Form Health Survey) were used. RESULTS: Thirty-eight percent of patients had moderate to high anxiety, and 22% had moderate to high depression; posttraumatic stress disorder was observed in 12%. The overall psychological comorbidity was 43% and 26% for a possible and probable psychiatric disorder. Disease progress, detrimental interactions, less social support, a lower educational level, and younger age were predictors of psychological comorbidity (P<.004). Lower QOL (P<.01) and higher levels of anxiety (P<.001) were observed in cancer survivors compared to age-adjusted normative comparison groups. Time since diagnosis had no significant impact on psychological comorbidity as well as QOL. Forty-six percent of women felt insufficiently informed about support offers. Insufficient knowledge was associated with older age and lower education (P<.05). Since diagnosis, 57% had participated in cancer rehabilitation and 24% in other psychosocial support programs. Fifteen percent of all patients and 23% of those with a possible psychiatric disorder expressed their need for psychosocial support. Women with distress and perceived support needs who did not participate in past support programs were older, less educated, and less informed (P<.05). CONCLUSION: Findings show the long-term impact of breast cancer and indicate need for patient education, screening for psychosocial distress, and implementation of psychological interventions tailored in particular for older women.
OBJECTIVE:Psychosocial comorbidity and quality of life (QOL) and its association with knowledge, utilization, and need for psychosocial support have been studied in long-term breast cancer survivors. METHODS: One thousand eighty-three patients were recruited through a population-based cancer registry an average of 47 months following diagnosis (66% response rate). Self-report measures (e.g., Hospital Anxiety and Depression Scale, Posttraumatic Stress Disorder Checklist--Civilian Version, and Short-Form Health Survey) were used. RESULTS: Thirty-eight percent of patients had moderate to high anxiety, and 22% had moderate to high depression; posttraumatic stress disorder was observed in 12%. The overall psychological comorbidity was 43% and 26% for a possible and probable psychiatric disorder. Disease progress, detrimental interactions, less social support, a lower educational level, and younger age were predictors of psychological comorbidity (P<.004). Lower QOL (P<.01) and higher levels of anxiety (P<.001) were observed in cancer survivors compared to age-adjusted normative comparison groups. Time since diagnosis had no significant impact on psychological comorbidity as well as QOL. Forty-six percent of women felt insufficiently informed about support offers. Insufficient knowledge was associated with older age and lower education (P<.05). Since diagnosis, 57% had participated in cancer rehabilitation and 24% in other psychosocial support programs. Fifteen percent of all patients and 23% of those with a possible psychiatric disorder expressed their need for psychosocial support. Women with distress and perceived support needs who did not participate in past support programs were older, less educated, and less informed (P<.05). CONCLUSION: Findings show the long-term impact of breast cancer and indicate need for patient education, screening for psychosocial distress, and implementation of psychological interventions tailored in particular for older women.
Authors: Francesca Romito; Claudia Cormio; Francesco Giotta; Giuseppe Colucci; Vittorio Mattioli Journal: Support Care Cancer Date: 2012-03-08 Impact factor: 3.603
Authors: D Howell; T F Hack; T K Oliver; T Chulak; S Mayo; M Aubin; M Chasen; C C Earle; A J Friedman; E Green; G W Jones; J M Jones; M Parkinson; N Payeur; C M Sabiston; S Sinclair Journal: J Cancer Surviv Date: 2012-07-10 Impact factor: 4.442
Authors: Eva Mazzotti; Gian Carlo Antonini Cappellini; Stefania Buconovo; Roberto Morese; Alessandro Scoppola; Claudia Sebastiani; Paolo Marchetti Journal: Support Care Cancer Date: 2012-01-21 Impact factor: 3.603
Authors: Neomi Vin-Raviv; Grace Clarke Hillyer; Dawn L Hershman; Sandro Galea; Nicole Leoce; Dana H Bovbjerg; Lawrence H Kushi; Candyce Kroenke; Lois Lamerato; Christine B Ambrosone; Heidis Valdimorsdottir; Lina Jandorf; Jeanne S Mandelblatt; Wei-Yann Tsai; Alfred I Neugut Journal: J Natl Cancer Inst Date: 2013-02-21 Impact factor: 13.506
Authors: Shaila M Strayhorn; Leslie R Carnahan; Kristine Zimmermann; Theresa A Hastert; Karriem S Watson; Carol Estwing Ferrans; Yamilé Molina Journal: Support Care Cancer Date: 2019-07-24 Impact factor: 3.603
Authors: K Ebenhan; K Leuteritz; Y Barthel; M E Beutel; K Papsdorf; G Weissflog; E Brähler Journal: Geburtshilfe Frauenheilkd Date: 2013-08 Impact factor: 2.915
Authors: Heide Götze; Michael Friedrich; Elmar Brähler; Georg Romer; Anja Mehnert; Jochen Ernst Journal: Support Care Cancer Date: 2016-09-13 Impact factor: 3.603